Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-01

Clinical Trial Update: Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates nitazoxanide for chronic diarrhea in HIV-infected children, covering Phase 1 and Phase 2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitazoxanide (nitazoxanide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Cryptosporidiosis | Phase 1, Phase 2 | Status: COMPLETED